The Prognostic Value of Epidermal Growth Factor Receptor (EGFR) in Breast Cancer Patients: Results of a follow-up study on 149 patients

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Follow Up Study ◽

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study

Breast Cancer Research and Treatment ◽

10.1007/bf00666183 ◽

1994 ◽

Vol 29 (1) ◽

pp. 73-83 ◽

Cited By ~ 91

Author(s):

Jan G. M. Klijn ◽

Maxime P. Look ◽

Henk Portengen ◽

Jana Alexieva-Figusch ◽

Wim L. J. van Putten ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Primary Breast Cancer ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Follow Up Study ◽

Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

Annals of Oncology ◽

10.1023/a:1011183421477 ◽

2001 ◽

Vol 12 (6) ◽

pp. 841-846 ◽

Cited By ~ 32

Author(s):

J.M. Ferrero ◽

A. Ramaioli ◽

R. Largillier ◽

J.L. Formento ◽

M. Francoual ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Breast Cancer Patients ◽

Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy

Scientific Reports ◽

10.1038/s41598-020-69965-1 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Soong June Bae ◽

Yoon Jin Cha ◽

Changik Yoon ◽

Dooreh Kim ◽

Janghee Lee ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

British Journal of Cancer ◽

10.1038/bjc.1991.30 ◽

1991 ◽

Vol 63 (1) ◽

pp. 146-150 ◽

Cited By ~ 123

Author(s):

S Nicholson ◽

J Richard ◽

C Sainsbury ◽

P Halcrow ◽

P Kelly ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Operable Breast Cancer ◽

Node Negative ◽

Follow Up Study ◽

Predictive Factors for Late (>5 Years) Distant Recurrences in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer Patients: >20 Year Follow Up

Austin Journal of Clinical Case Reports ◽

10.26420/austinjclincaserep.2017.1119 ◽

2017 ◽

Vol 4 (2) ◽

Author(s):

Jaskirat Randhawa

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Predictive Factors ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Predictive factors for late (>5 years) distant recurrences in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients: >20-year follow-up.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.543 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 543-543

Author(s):

Jaskirat Singh Randhawa ◽

Sina Shafiei ◽

Mykola Onyshchenko ◽

Susmita Sakruti ◽

Rohan Garje ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Er Positive ◽

Prognostic Value of Estrogen and Progesterone Receptor Expression in Low Proliferative Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Journal of Breast Disease ◽

10.14449/jbd.2017.5.2.64 ◽

2017 ◽

Vol 5 (2) ◽

pp. 64-70

Author(s):

Yujin Lee ◽

Inseok Park ◽

Hyunjin Cho ◽

Keunho Yang ◽

Jungbin Kim ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen And Progesterone Receptor

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Progesterone Receptor Expression ◽

Epidermal Growth ◽

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-0862-7 ◽

2010 ◽

Vol 124 (2) ◽

pp. 497-507 ◽

Cited By ~ 25

Author(s):

Patricia R. Blank ◽

Matthias Schwenkglenks ◽

Holger Moch ◽

Thomas D. Szucs

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Effectiveness Analysis ◽

Epidermal Growth ◽

Predictive Assay

Benefit of Gonadotropin-releasing Hormone (GnRH) agonist administration with Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2-Negative subtype for young breast cancer patients

The Breast ◽

10.1016/s0960-9776(17)30344-2 ◽

2017 ◽

Vol 32 ◽

pp. S108

Author(s):

T.I. Yoon ◽

S.B. Lee ◽

G. Sohn ◽

B.S. Ko ◽

J.W. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Hormone Receptor Positive ◽

Epidermal Growth ◽

Young Breast Cancer